Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ischemic Heart Disease

  Free Subscription


11.10.2021

3 Am Heart J
3 Am J Cardiol
1 Ann Thorac Surg
1 Atherosclerosis
1 Br J Haematol
6 Cardiovasc Res
1 Circ Cardiovasc Imaging
1 Circ Cardiovasc Interv
1 Circ J
1 Circ Res
4 Circulation
4 Eur Heart J
2 Hypertension
1 Int J Cardiol
5 J Am Coll Cardiol
1 J Electrocardiol
6 J Mol Cell Cardiol
1 JAMA
2 Mayo Clin Proc
1 PLoS Med
4 PLoS One
1 Prog Cardiovasc Dis
2 Thromb Haemost


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. WEAVER AM, McGuinn LA, Neas L, Devlin RB, et al
    Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients.
    Am Heart J. 2021 Oct 2. pii: S0002-8703(21)00243.
    PubMed         Abstract available

  2. MERT GO, Babayigit E, Gorenek B
    The value of performing thorough echocardiography in patients with coronary heart disease and atrial fibrillation.
    Am Heart J. 2021;241:121.
    PubMed        

  3. PANKAYATSELVAN V, Mukamal KJ
    Influenza Vaccination Among Adults with Cardiovascular Disease in the United States: Results from the Behavioral Risk Factor Surveillance System 2018-2019.
    Am Heart J. 2021 Sep 29. pii: S0002-8703(21)00233.
    PubMed         Abstract available


    Am J Cardiol

  4. ELKARYONI A, Elgendy IY, Manshad A, Desai N, et al
    Trends and Outcomes of Transferred Patients With ST-Elevation Myocardial Infarction from Acute Care Hospitals (from a Nationwide Analysis).
    Am J Cardiol. 2021 Oct 2. pii: S0002-9149(21)00815.
    PubMed        

  5. KIM TO, Ahn JM, Kang DY, Park H, et al
    Long-Term Outcomes After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents or Coronary Artery Bypass Grafting for Multivessel Coronary Disease.
    Am J Cardiol. 2021 Oct 2. pii: S0002-9149(21)00825.
    PubMed         Abstract available

  6. CASE BC, Abramowitz J, Shea C, Rappaport H, et al
    Evolution of Management and Outcomes of Patients with Myocardial Injury During the COVID-19 Pandemic.
    Am J Cardiol. 2021;157:42-47.
    PubMed         Abstract available


    Ann Thorac Surg

  7. UNZUE L, Moreno L, Garcia E
    Thrombotic Occlusion of a Giant Coronary Aneurysm After David Procedure.
    Ann Thorac Surg. 2021;112:e313.
    PubMed        


    Atherosclerosis

  8. KRISTIANSEN O, Sverre E, Peersen K, Fagerland MW, et al
    The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease.
    Atherosclerosis. 2021;336:23-29.
    PubMed         Abstract available


    Br J Haematol

  9. YING L, Wang J, Li J, Teng J, et al
    Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on-treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)-2 Trial.
    Br J Haematol. 2021 Oct 5. doi: 10.1111/bjh.17847.
    PubMed         Abstract available


    Cardiovasc Res

  10. CORCORAN D, Radjenovic A, Mordi IR, Nazir SA, et al
    Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trial.
    Cardiovasc Res. 2021;117:320-329.
    PubMed         Abstract available

  11. LI Y, Yan H, Guo J, Han Y, et al
    Down-regulated RGS5 by genetic variants impairs endothelial cell function and contributes to coronary artery disease.
    Cardiovasc Res. 2021;117:240-255.
    PubMed         Abstract available

  12. AMANAKIS G, Sun J, Fergusson MM, McGinty S, et al
    Cysteine 202 of cyclophilin D is a site of multiple post-translational modifications and plays a role in cardioprotection.
    Cardiovasc Res. 2021;117:212-223.
    PubMed         Abstract available

  13. MOLITOR M, Rudi WS, Garlapati V, Finger S, et al
    Nox2+ Myeloid cells drive vascular inflammation and endothelial dysfunction in heart failure after myocardial infarction via angiotensin II receptor type 1.
    Cardiovasc Res. 2020 Feb 20. pii: 5741408. doi: 10.1093.
    PubMed         Abstract available

  14. NAKASHIMA Y, Sakai Y, Mizuno Y, Furuno K, et al
    Lipidomics links oxidized phosphatidylcholines and coronary arteritis in Kawasaki disease.
    Cardiovasc Res. 2021;117:96-108.
    PubMed         Abstract available

  15. LIMA CORREA B, El Harane N, Gomez I, Rachid Hocine H, et al
    Extracellular vesicles from human cardiovascular progenitors trigger a reparative immune response in infarcted hearts.
    Cardiovasc Res. 2021;117:292-307.
    PubMed         Abstract available


    Circ Cardiovasc Imaging

  16. PEZEL T, Unterseeh T, Garot P, Hovasse T, et al
    Long-Term Prognostic Value of Stress Cardiovascular Magnetic Resonance-Related Coronary Revascularization to Predict Death: A Large Registry With >200 000 Patient-Years of Follow-Up.
    Circ Cardiovasc Imaging. 2021 Oct 6:CIRCIMAGING121012789.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  17. KHURANA A, Obaid D, Chase A, Smith D, et al
    Kissing the Chimney: Managing a Protuberant Coronary Stent During Transcatheter Aortic Valve Replacement.
    Circ Cardiovasc Interv. 2021 Oct 6:CIRCINTERVENTIONS121011031.
    PubMed        


    Circ J

  18. ISHIDA M, Ishisone T, Kimura T, Morino Y, et al
    Stent-Less Percutaneous Coronary Intervention of Calcified Nodule Causing Non-ST-Elevation Myocardial Infarction- Serial Optical Coherence Tomography Follow-up After Rotational Atherectomy Followed by Drug-Coated Balloon Angioplasty.
    Circ J. 2021 Oct 1. doi: 10.1253/circj.CJ-21-0628.
    PubMed        


    Circ Res

  19. ZHANG QJ, He Y, Li Y, Shen H, et al
    Matricellular Protein Cilp1 Promotes Myocardial Fibrosis in Response to Myocardial Infarction.
    Circ Res. 2021 Oct 6. doi: 10.1161/CIRCRESAHA.121.319482.
    PubMed         Abstract available


    Circulation

  20. GENCER B, Djousse L, Al-Ramady OT, Cook NR, et al
    Effect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
    Circulation. 2021 Oct 6. doi: 10.1161/CIRCULATIONAHA.121.055654.
    PubMed         Abstract available

  21. CHOI S, Lee K, Park SM
    Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study.
    Circulation. 2021 Oct 4. doi: 10.1161/CIRCULATIONAHA.121.054967.
    PubMed        

  22. GAUDINO M, Sandner S, Di Giammarco G, Di Franco A, et al
    The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements.
    Circulation. 2021;144:1160-1171.
    PubMed         Abstract available

  23. RUEL M, Fischbein M
    Introduction to the 2021 Cardiovascular Surgery Themed Issue of Circulation.
    Circulation. 2021;144:1087.
    PubMed        


    Eur Heart J

  24. YANG Q, Sun D, Pei C, Zeng Y, et al
    LDL cholesterol levels and in-hospital bleeding in patients on high-intensity antithrombotic therapy: findings from the CCC-ACS project.
    Eur Heart J. 2021;42:3175-3186.
    PubMed         Abstract available

  25. CERRATO E, Giacobbe F, Quadri G, Macaya F, et al
    Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.
    Eur Heart J. 2021;42:3161-3171.
    PubMed         Abstract available

  26. GOROG DA, Navarese EP, Andreotti F
    Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
    Eur Heart J. 2021 Jul 29. pii: 6330652. doi: 10.1093.
    PubMed        

  27. CREA F
    Pulmonary embolism, COVID, and bleeding risk in acute coronary syndromes: a Focus Issue on thrombosis and antithrombotic treatment.
    Eur Heart J. 2021;42:3109-3113.
    PubMed        


    Hypertension

  28. VASAN RS, Pan S, Larson MG, Mitchell GF, et al
    Arteriosclerosis, Atherosclerosis, and Cardiovascular Health: Joint Relations to the Incidence of Cardiovascular Disease.
    Hypertension. 2021 Oct 4:HYPERTENSIONAHA12118075.
    PubMed         Abstract available

  29. VASAN RS, Song RJ, Xanthakis V, Mitchell GF, et al
    Aortic Root Diameter and Arterial Stiffness: Conjoint Relations to the Incidence of Cardiovascular Disease in the Framingham Heart Study.
    Hypertension. 2021 Oct 4:HYPERTENSIONAHA12117702.
    PubMed         Abstract available


    Int J Cardiol

  30. PARK S, Kim YG, Ann SH, Park HW, et al
    Ticagrelor versus prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Oct 4. pii: S0167-5273(21)01505.
    PubMed         Abstract available


    J Am Coll Cardiol

  31. SULLIVAN AE, Nanna MG, Wang TY, Bhatt DL, et al
    Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:1550-1563.
    PubMed         Abstract available

  32. LEE HH, Lee H, Cho SMJ, Kim DW, et al
    On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular Hypertrophy.
    J Am Coll Cardiol. 2021;78:1485-1495.
    PubMed         Abstract available

  33. BOS D, Arshi B, van den Bouwhuijsen QJA, Ikram MK, et al
    Atherosclerotic Carotid Plaque Composition and Incident Stroke and Coronary Events.
    J Am Coll Cardiol. 2021;77:1426-1435.
    PubMed         Abstract available

  34. JOHANNESEN CDL, Mortensen MB, Langsted A, Nordestgaard BG, et al
    Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients.
    J Am Coll Cardiol. 2021;77:1439-1450.
    PubMed         Abstract available

  35. DE BRUYNE B, Pijls NHJ, Gallinoro E, Candreva A, et al
    Microvascular Resistance Reserve for Assessment of Coronary Microvascular Function: JACC Technology Corner.
    J Am Coll Cardiol. 2021;78:1541-1549.
    PubMed         Abstract available


    J Electrocardiol

  36. WANG W, Zhang Q
    Diagnostic value of scoring model of treadmill exercise test combined with dynamic electrocardiogram for latent coronary heart disease.
    J Electrocardiol. 2021;69:82-86.
    PubMed         Abstract available


    J Mol Cell Cardiol

  37. XING W, Tan Y, Li K, Tian P, et al
    Upregulated hepatokine fetuin B aggravates myocardial ischemia/reperfusion injury through inhibiting insulin signaling in diabetic mice.
    J Mol Cell Cardiol. 2021;151:163-172.
    PubMed         Abstract available

  38. KAYVANPOUR E, Gi WT, Sedaghat-Hamedani F, Lehmann DH, et al
    microRNA neural networks improve diagnosis of acute coronary syndrome (ACS).
    J Mol Cell Cardiol. 2021;151:155-162.
    PubMed         Abstract available

  39. MISTRY P, Reitz CJ, Khatua TN, Rasouli M, et al
    Circadian influence on the microbiome improves heart failure outcomes.
    J Mol Cell Cardiol. 2020 Sep 19. pii: S0022-2828(20)30286.
    PubMed         Abstract available

  40. ROLLE IG, Crivellari I, Zanello A, Mazzega E, et al
    Heart failure impairs the mechanotransduction propeties of human cardiac pericytes.
    J Mol Cell Cardiol. 2020;151:15-30.
    PubMed         Abstract available

  41. WANG X, Wan TC, Lauth A, Purdy AL, et al
    Conditional depletion of the acetyltransferase Tip60 protects against the damaging effects of myocardial infarction.
    J Mol Cell Cardiol. 2021 Oct 2. pii: S0022-2828(21)00189.
    PubMed         Abstract available

  42. AGHAJANIAN A, Zhang H, Buckley BK, Wittchen ES, et al
    Decreased inspired oxygen stimulates de novo formation of coronary collaterals in adult heart.
    J Mol Cell Cardiol. 2021;150:1-11.
    PubMed         Abstract available


    JAMA

  43. HE J, Zhu Z, Bundy JD, Dorans KS, et al
    Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018.
    JAMA. 2021;326:1286-1298.
    PubMed         Abstract available


    Mayo Clin Proc

  44. BELL EJ, Bielinski SJ, St Sauver JL, Chen LY, et al
    Association of Proton Pump Inhibitors With Higher Risk of Cardiovascular Disease and Heart Failure.
    Mayo Clin Proc. 2021;96:2540-2549.
    PubMed         Abstract available

  45. MALIK N, Weintraub WS
    The Cardiovascular Risk of Proton Pump Inhibitors and the Dangers of Polypharmacy.
    Mayo Clin Proc. 2021;96:2511-2513.
    PubMed        


    PLoS Med

  46. PINHO-GOMES AC, Azevedo L, Copland E, Canoy D, et al
    Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
    PLoS Med. 2021;18:e1003599.
    PubMed         Abstract available


    PLoS One

  47. CALLING S, Johansson SE, Nymberg VM, Sundquist J, et al
    Trajectories of body mass index and risk for coronary heart disease: A 38-year follow-up study.
    PLoS One. 2021;16:e0258395.
    PubMed         Abstract available

  48. WANHA W, Januszek R, Kolodziejczak M, Kuzma L, et al
    Procedural and 1-year outcomes following large vessel coronary artery perforation treated by covered stents implantation: Multicentre CRACK registry.
    PLoS One. 2021;16:e0249698.
    PubMed         Abstract available

  49. SAKAKURA K, Taniguchi Y, Yamamoto K, Tsukui T, et al
    Modifiable and unmodifiable factors associated with slow flow following rotational atherectomy.
    PLoS One. 2021;16:e0250757.
    PubMed         Abstract available

  50. RUFF C, Gerharz A, Groll A, Stoll F, et al
    Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
    PLoS One. 2021;16:e0250298.
    PubMed         Abstract available


    Prog Cardiovasc Dis

  51. MONTONE RA, Jang IK, Beltrame JF, Sicari R, et al
    The evolving role of cardiac imaging in patients with myocardial infarction and non-obstructive coronary arteries.
    Prog Cardiovasc Dis. 2021 Sep 30. pii: S0033-0620(21)00096.
    PubMed         Abstract available


    Thromb Haemost

  52. YAMASHITA A, Nishihira K, Gi T, Maekawa K, et al
    Pathological Features of Ruptured Coronary Plaque and Thrombus Interfaces: Fibrin and von Willebrand Factor as Platelet Scaffolds on Rupture Sites.
    Thromb Haemost. 2021;121:234-241.
    PubMed         Abstract available

  53. VAN PARIDON PCS, Panova-Noeva M, van Oerle R, Schulz A, et al
    Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.
    Thromb Haemost. 2021;121:174-181.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: